Exhibit 99.1

Joint Filing Agreement

The undersigned hereby agree that the Statement on Schedule 13G dated August 17, 2026 with respect to the Voting Common Stock, par value $0.0001 per share, of Jasper Therapeutics, Inc., and any amendments thereto executed by each and any of the undersigned shall be filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.

Velan Capital Master Fund LP
 
By:

/s/ Adam Morgan

 
  Adam Morgan, Managing Member of Velan Capital Holdings LLC, its General Partner
Date: 08/17/2026

 

Velan Capital Holdings LLC
 
By:

/s/ Adam Morgan

 
  Adam Morgan, Managing Member
Date: 08/17/2026

 

Velan Horizon Fund LP
 
By:

/s/ Adam Morgan

 
  Adam Morgan, Managing Member of Velan Horizon GP LLC, its General Partner
Date: 08/17/2026

 

Velan Horizon GP LLC
 
By:

/s/ Adam Morgan

 
  Adam Morgan, Managing Member
Date: 08/17/2026

 

Avego Healthcare Capital, L.P.
 
By:

/s/ Balaji Venkataraman

 
  Balaji Venkataraman, Managing Member of Avego Healthcare Capital Holdings, LLC, its General Partner
Date: 08/17/2026

 

Avego Healthcare Capital Holdings, LLC
 
By:

/s/ Balaji Venkataraman

 
  Balaji Venkataraman, Managing Member
Date: 08/17/2026

 

 

 

 

Avego Management LLC
 
By:

/s/ Balaji Venkataraman

 
  Balaji Venkataraman, Managing Member
Date: 08/17/2026

 

Velan Capital Investment Management LP
 
By:

/s/ Adam Morgan

 
  Adam Morgan, Managing Member of Velan Capital Management LLC, its General Partner
Date: 08/17/2026

 

Velan Capital Management LLC
 
By:

/s/ Adam Morgan

 
  Adam Morgan, Managing Member
Date: 08/17/2026

 

Morgan Adam
 
By:

/s/ Adam Morgan

 
  Adam Morgan
Date: 08/17/2026

 

VENKATARAMAN BALAJI
 
By:

/s/ Balaji Venkataraman

 
  Balaji Venkataraman
Date: 08/17/2026

 

Kapoor Vishal
 
By:

/s/ Vishal Kapoor

 
  Vishal Kapoor
Date: 08/17/2026